Drugs / GSK576428
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00333021 | May 2006 → Feb 2007 | venous thromboembolism | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK576428 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00333021 ↗ |